Conduct phase 3 trial of plaque psoriasis FDC drug on Indian patients: CDSCO panel tells Glenmark Medical Dialogues Team22 Aug 2021 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Glenmark Pharmaceuticals...
Glenmark gets CDSCO panel nod for manufacturing, marketing Itraconazole Capsules Medical Dialogues Team15 Aug 2021 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
Glenmark profit after tax up 21 percent at Rs 306 crore in Q1 Ruchika Sharma15 Aug 2021 9:00 AM ISTNew Delhi: Glenmark Pharmaceuticals on Friday said its consolidated profit after tax (PAT) increased by 21 per cent to Rs 306 crore for the first...
Fitch affirms Glenmark at BB on IPO of API business Ruchika Sharma10 Aug 2021 1:15 PM ISTSingapore: Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient...
Glenmark, SaNOtize collaborate to commercialize Nitric Oxide Nasal Spray for COVID-19 in Asian markets Ruchika Sharma2 Aug 2021 2:54 PM ISTNitric Oxide Nasal Spray is one of the few novel therapeutic treatments, outside of expensive monoclonal antibodies, that is proven to reduce...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Glenmark to conduct phase 3 trials of nasal spray it claims to be effective in COVID treatment Ruchika Sharma10 July 2021 12:15 PM ISTNew Delhi: Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of...
Fitch affirms Glenmark issuer default rating at BB with stable outlook Ruchika Sharma6 July 2021 12:30 PM ISTSingapore: Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.It said Glenmark's...
Glenmark bags USFDA nod for Nintedanib Capsules Ruchika Sharma25 Jun 2021 10:55 AM ISTMumbai: Drug maker, Glenmark Pharmaceuticals Ltd, today announced that the company has received tentative approval from the United States Food &...
Include cardiology parameters in clinical trial of anti diabetic drug Lobeglitazone: CDSCO panel tells Glenmark Medical Dialogues Team22 Jun 2021 2:54 PM ISTNew Delhi: In accordance with the proposal presented by pharma major, Glenmark, on the anti-diabetic drug molecule, Lobeglitazone Sulphate Tablets,...
Glenmark gets CDSCO panel nod to revise phase 4 protocol for Minocycline Hydrochloride Topical Gel Medical Dialogues Team16 Jun 2021 9:30 AM ISTNew Delhi: Responding to the phase IV protocol for Minocycline Hydrochloride Topical Gel 4% for topical use presented by Glenmark Pharma, the Subject...
Glenmark Life Sciences, Utkarsh Small Finance Bank get SEBI go ahead to float IPO Ruchika Sharma10 Jun 2021 11:57 AM ISTNew Delhi: Utkarsh Small Finance Bank and Glenmark Life Sciences have received capital markets regulator Sebi's go ahead to raise funds through...
